Affordable Access

deepdyve-link
Publisher Website

Nanobodies: new avenue to treat kidney disease

Authors
  • Wanner, Nicola1
  • Eden, Thomas1
  • Liaukouskaya, Nastassia1
  • Koch-Nolte, Friedrich1
  • 1 University Medical Center Hamburg-Eppendorf (UKE),
Type
Published Article
Journal
Cell and Tissue Research
Publisher
Springer-Verlag
Publication Date
Jun 16, 2021
Pages
1–12
Identifiers
DOI: 10.1007/s00441-021-03479-8
PMID: 34131806
PMCID: PMC8205650
Source
PubMed Central
Keywords
Disciplines
  • Review
License
Unknown

Abstract

Current therapeutic options for renal diseases are limited, and the search for disease-specific treatments is ongoing. Nanobodies, single-domain antibodies with many advantages over conventional antibodies, provide flexible, easy-to-format biologicals with many possible applications. Here, we discuss the potential use of nanobodies for renal diseases.

Report this publication

Statistics

Seen <100 times